Equities

Creo Medical Group PLC

Creo Medical Group PLC

Actions
  • Price (EUR)0.394
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+33.11%
  • Beta--
Data delayed at least 15 minutes, as of Apr 23 2024 14:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, Creo Medical Group PLC (1RC:FRA) traded at 0.394, 49.24% above the 52 week low of 0.264 set on Jun 08, 2023.
52-week range
Today
0.264Jun 08 20230.545Jan 03 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.384
High0.394
Low0.384
Bid0.386
Offer0.434
Previous close0.394
Average volume0.00
Shares outstanding361.48m
Free float286.96m
P/E (TTM)--
Market cap125.61m GBP
EPS (TTM)-0.1139
GBP
Data delayed at least 15 minutes, as of Apr 23 2024 14:29 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.